Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,479 across all filing types
Latest filing 2022-04-19 Transaction in Own Shar…
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Coloplast A/S - Transactions in connection with share buy-back programme, week 15
Transaction in Own Shares Classification · 1% confidence The document is a report detailing the company's share buy-back transactions for a specific week (week 15). It explicitly mentions the initiation of a share buy-back programme and provides a table of executed transactions, which aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2022-04-19 Danish
Transaction in Own Shares 2022
Transaction in Own Shares Classification · 1% confidence The document is explicitly titled "Coloplast – transactions in connection with share buy-back programme, week 14". It details the execution of share transactions (purchases) under a previously announced share buyback program, including the number of shares bought and the transaction value for the period of April 4 – 8, 2022. This content directly relates to the company managing its own stock, which corresponds to the definition of 'Transaction in Own Shares' (POS). It is not a general management change (MANG), a director's personal trade (DIRS), or a general financing update (CAP), but a specific report on treasury share activity.
2022-04-11 English
Transaction in Own Shares 2022
Transaction in Own Shares Classification · 1% confidence The document title is "Coloplast A/S - Transaktioner i henhold til aktietilbagekøbsprogram, uge 14" (Transactions pursuant to share buyback program, week 14). The text details the ongoing share repurchase program, including the period covered (April 4-8, 2022), the number of shares bought back, and the accumulated total. This activity directly relates to the company managing its own stock, which falls under the definition of 'Transaction in Own Shares'. The code for this is POS. The document is a formal announcement detailing the transaction, not just an announcement that a report is attached (RPA), as the core data is present.
2022-04-11 Danish
Coloplast A/S - Transactions in connection with share buy-back programme, week 14
Transaction in Own Shares Classification · 1% confidence The document is a detailed report of Coloplast's share buyback transactions for week 14 of 2022. It explicitly references the EU Market Abuse Regulation (MAR) and provides a granular, trade-by-trade breakdown of share repurchases (date, time, price, volume, and venue). This falls directly under the category of 'Transaction in Own Shares' (POS).
2022-04-11 English
Coloplast A/S - Transactions in connection with share buy-back programme, week 14
Transaction in Own Shares Classification · 1% confidence The document is a corporate announcement from Coloplast detailing transactions made under their share buyback program for the week of April 4-8, 2022. It explicitly mentions the 'aktietilbagekøbsprogram' (share buyback program) and provides a table of shares purchased, average price, and total transaction value. This falls directly under the definition of 'Transaction in Own Shares' (POS).
2022-04-11 Danish
Coloplast A/S - Transactions in connection with share buy-back programme, week 14
Transaction in Own Shares Classification · 1% confidence The document is a detailed report of Coloplast's share buy-back transactions for a specific week (week 14, 2022). It explicitly references 'Article 5 of Regulation No 596/2014' (MAR) and provides a granular, trade-by-trade breakdown of share repurchases, which is the standard format for 'Transaction in Own Shares' filings. It is not a general regulatory announcement (RNS) or a report publication announcement (RPA) because it contains the primary transaction data itself.
2022-04-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.